Evidence map›Paper›PMID 40442174›Full record

ArticleScientific reports2025

Risk factors associated with community colonization of extended-spectrum cephalosporin-resistant Enterobacterales from an antibiotic resistance in communities and hospitals (ARCH) study, Guatemala.

Brooke M Ramay, Mark A Caudell, Carmen Castillo, Laura Grajeda, Lucas F Santos, Juan Carlos Romero, Maria Renee Lopez, Sylvia Omulo, Mariangeli Freitas Ning, Guy H Palmer and 5 more

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Brooke M Ramay *Paul G. Allen School for Global Health, Washington State University, Pullman, WA, USA. brooke.ramay@wsu.edu.ORCID http://orcid.org/0000-0001-8527-4067
Mark A Caudell *Paul G. Allen School for Global Health, Washington State University, Pullman, WA, USA.
Carmen CastilloPaul G. Allen School for Global Health, Washington State University, Pullman, WA, USA.
Laura GrajedaCenter for Health Studies, Universidad del Valle de Guatemala, Guatemala City, Guatemala.
Lucas F SantosCenter for Health Studies, Universidad del Valle de Guatemala, Guatemala City, Guatemala.
Juan Carlos RomeroCenter for Health Studies, Universidad del Valle de Guatemala, Guatemala City, Guatemala.
Maria Renee LopezCenter for Health Studies, Universidad del Valle de Guatemala, Guatemala City, Guatemala.
Sylvia OmuloPaul G. Allen School for Global Health, Washington State University, Pullman, WA, USA.
Mariangeli Freitas NingCentral America Regional Office, U.S. Centers for Disease Control and Prevention, Guatemala City, Guatemala.
Guy H PalmerPaul G. Allen School for Global Health, Washington State University, Pullman, WA, USA.
Rachel M SmithDivision of Healthcare Quality Promotion, U.S. Centers for Disease Control and Prevention, Atlanta, USA.
Carolyn T A HerzigDivision of Healthcare Quality Promotion, U.S. Centers for Disease Control and Prevention, Atlanta, USA.
Ashley StyczynskiDivision of Healthcare Quality Promotion, U.S. Centers for Disease Control and Prevention, Atlanta, USA.
Celia Cordon-RosalesPaul G. Allen School for Global Health, Washington State University, Pullman, WA, USA.
Douglas R CallPaul G. Allen School for Global Health, Washington State University, Pullman, WA, USA.

Funding

U.S. Department of Health & Human Services | CDC | National Center for Emerging and Zoonotic Infectious Diseases (NCEZID) U01GH002143
6 · The paper itself

Abstract

Colonization with extended-spectrum cephalosporin-resistant Enterobacterales (ESCrE) in communities may contribute to proliferation of resistance genes and drug-resistant community and hospital infections. Previous work in the Western Highlands of Guatemala found that approximately 46% of the population is colonized with these bacteria, setting the stage to identify factors that are associated with increased odds of ESCrE colonization. Stool samples and questionnaire data were collected from randomly selected participants in the catchment area of the third largest tertiary hospital in Guatemala. Logistic regression path analysis was used for this cross-sectional study to identify potential direct and indirect risk factors for colonization with ESCrE. Participants (N = 951) had a higher odds of ESCrE colonization if they had exposure to a healthcare facility within 30 days of enrollment (OR: 2.12, 95% CI = 1.19-3.77), if they resided in urban areas (OR: 1.93, 95% CI 1.09-3.42), if they did not have a service to remove household trash (OR: 1.99, 95% CI 1.11-3.58), and if the household reported drinking water from non-bottled sources (OR:1.53, 95% CI 1.0-2.33). Antibiotic self-medication was not significantly associated with the risk of colonization (OR: 1.16, 95% CI 0.65-2.06). Multiple transmission-related factors were associated with increased likelihood of ESCrE colonization, but the cross-sectional nature of this study does not distinguish factors that are correlated with an individual's risk for colonization whence exposed. Assessing risk factors associated with colonization with antibiotic resistant bacteria may be useful for identifying mitigation strategies and evaluating the effectiveness of interventions against antibiotic resistance in community settings.

Indexed as

Cephalosporin ResistanceCephalosporinsDrug Resistance, BacterialEnterobacteriaceaeEnterobacteriaceae InfectionsAdolescentAdultAgedAnti-Bacterial AgentsCross-Sectional StudiesFecesFemaleGuatemalaHospitalsHumansMaleAnti-Bacterial AgentsCephalosporinsColonizationCommunitiesExtended-spectrum cephalosporin-resistant EnterobacteralesGuatemala

Identifiers

PMID40442174
PMCPMC12122697

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.